AI assistant
Sending…
Pacira BioSciences, Inc. — Director's Dealing 2016
May 5, 2016
32125_dirs_2016-05-04_1a641345-95e3-48de-89dc-f4ff68d7a2a9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2016-05-03
Reporting Person: Reinhart Charles A. III (Chief Financial Officer)
More from Pacira BioSciences, Inc.
Proxy Solicitation & Information Statement
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 27
Proxy Solicitation & Information Statement
2026
May 26
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 19
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 12
Interim / Quarterly Report
2026
Apr 30